This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
This BP Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday
這位BP分析師不再看好；以下是週二的前五次下調評級
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
華爾街頂級分析師改變了對這些頂級公司的展望。如需查看包括升級和降級在內的所有分析師評級變化的完整視圖，請參閱我們的分析師評級頁面。
- HSBC analyst Charlene Liu downgraded the rating for Baidu, Inc. (NASDAQ:BIDU) from Buy to Hold and announced a price target of $100. Baidu shares gained 2.4% to close at $88.28 on Monday. See how other analysts view this stock.
- Redburn Atlantic analyst Peter Low downgraded the rating for BP p.l.c. (NYSE:BP) from Buy to Neutral. BP shares gained 0.7% to close at $32.86 on Monday. See how other analysts view this stock.
- Baird analyst Eric Coldwell downgraded McKesson Corporation (NYSE:MCK) from Outperform to Neutral and lowered the price target from $603 to $531. McKesson shares fell 0.6% to close at $505.00 on Monday. See how other analysts view this stock.
- Leerink Partners analyst Andrew Berens downgraded the rating for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Outperform to Market Perform, while cutting the price target from $1,175 to $1,077. Regeneron Pharmaceuticals shares fell 4.6% to close at $1,091.98 on Monday. See how other analysts view this stock.
- Wedbush analyst David Chiaverini downgraded First Horizon Corporation (NYSE:FHN) from Outperform to Neutral and slashed the price target from $20 to $17. First Horizon shares fell 1.9% to close at $15.67 on Monday. See how other analysts view this stock.
- 匯豐銀行分析師劉嘉琪將百度公司（納斯達克:BIDU）的評級從買入降級爲持有，並公佈了$100的目標價。週一，百度股價上漲2.4%，收於$88.28。查看其他分析師如何看待這隻股票。
- Redburn Atlantic分析師彼得·勞下調了BP p.l.c.（紐交所:BP）的評級，從買入降級爲中立。週一，BP股價上漲0.7%，收於$32.86。查看其他分析師如何看待這隻股票。
- Baird分析師埃裏克·科德威爾將麥克森公司（紐交所:MCK）的評級從表現優異降級爲中立，並將目標價從$603下調至$531。週一，麥克森股價下跌0.6%，收於$505.00。查看其他分析師如何看待這隻股票。
- Leerink Partners分析師安德魯·貝倫斯將再生元製藥公司（納斯達克:REGN）的評級從表現優異降級爲市場表現，同時將目標價從$1,175下調至$1,077。週一，再生元製藥股價下跌4.6%，收於$1,091.98。查看其他分析師如何看待這隻股票。
- Wedbush分析師大衛·基亞維里尼將First Horizon Corporation（紐交所:FHN）的評級從表現優異降級爲中立，並將目標價從$20下調至$17。週一，First Horizon股價下跌1.9%，收於$15.67。查看其他分析師如何看待這隻股票。
Considering buying BP stock? Here's what analysts think:
考慮購買BP股票嗎？以下是分析師的看法：
- Jim Cramer Says This Utilities Stock Is A Buy: 'We Need Cheap Power'
- 吉姆·克雷默說，這家公用事業股票是一個買入：'我們需要廉價電力'
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。